These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30038216)

  • 21. Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activity.
    Karmakar S; Jin Y; Nagaich AK
    J Biol Chem; 2013 Aug; 288(33):24020-34. PubMed ID: 23814048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenomics-based identification of oestrogen-regulated long noncoding RNAs in ER+ breast cancer.
    Zhang Z; Yu W; Tang D; Zhou Y; Bi M; Wang H; Zheng Y; Chen M; Li L; Xu X; Zhang W; Tao H; Jin VX; Liu Z; Chen L
    RNA Biol; 2020 Nov; 17(11):1590-1602. PubMed ID: 32506995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Luminal lncRNAs Regulation by ERα-Controlled Enhancers in a Ligand-Independent Manner in Breast Cancer Cells.
    Miano V; Ferrero G; Rosti V; Manitta E; Elhasnaoui J; Basile G; De Bortoli M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer.
    Perone Y; Farrugia AJ; Rodríguez-Meira A; Győrffy B; Ion C; Uggetti A; Chronopoulos A; Marrazzo P; Faronato M; Shousha S; Davies C; Steel JH; Patel N; Del Rio Hernandez A; Coombes C; Pruneri G; Lim A; Calvo F; Magnani L
    Nat Commun; 2019 May; 10(1):2115. PubMed ID: 31073170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells.
    Mahalingaiah PK; Ponnusamy L; Singh KP
    Breast Cancer Res Treat; 2015 Aug; 153(1):41-56. PubMed ID: 26208486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells.
    Lopes R; Korkmaz G; Revilla SA; van Vliet R; Nagel R; Custers L; Kim Y; van Breugel PC; Zwart W; Moumbeini B; Manber Z; Elkon R; Agami R
    Cancer Lett; 2018 Nov; 436():87-95. PubMed ID: 30145202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer.
    Magnani L; Patten DK; Nguyen VT; Hong SP; Steel JH; Patel N; Lombardo Y; Faronato M; Gomes AR; Woodley L; Page K; Guttery D; Primrose L; Fernandez Garcia D; Shaw J; Viola P; Green A; Nolan C; Ellis IO; Rakha EA; Shousha S; Lam EW; Győrffy B; Lupien M; Coombes RC
    Oncotarget; 2015 Sep; 6(26):21878-91. PubMed ID: 26215677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SRC-3 Coactivator Governs Dynamic Estrogen-Induced Chromatin Looping Interactions during Transcription.
    Panigrahi AK; Foulds CE; Lanz RB; Hamilton RA; Yi P; Lonard DM; Tsai MJ; Tsai SY; O'Malley BW
    Mol Cell; 2018 May; 70(4):679-694.e7. PubMed ID: 29775582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The LIM protein Ajuba recruits DBC1 and CBP/p300 to acetylate ERα and enhances ERα target gene expression in breast cancer cells.
    Xu B; Li Q; Chen N; Zhu C; Meng Q; Ayyanathan K; Qian W; Jia H; Wang J; Ni P; Hou Z
    Nucleic Acids Res; 2019 Mar; 47(5):2322-2335. PubMed ID: 30597111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen induces dynamic ERα and RING1B recruitment to control gene and enhancer activities in luminal breast cancer.
    Zhang Y; Chan HL; Garcia-Martinez L; Karl DL; Weich N; Slingerland JM; Verdun RE; Morey L
    Sci Adv; 2020 Jun; 6(23):eaaz7249. PubMed ID: 32548262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.
    Karmakar S; Gao T; Pace MC; Oesterreich S; Smith CL
    Mol Endocrinol; 2010 Jun; 24(6):1187-202. PubMed ID: 20392877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing.
    Robbez-Masson LJ; Bödör C; Jones JL; Hurst HC; Fitzgibbon J; Hart IR; Grose RP
    PLoS One; 2013; 8(11):e78839. PubMed ID: 24265722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
    Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
    Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.
    Millour J; Constantinidou D; Stavropoulou AV; Wilson MS; Myatt SS; Kwok JM; Sivanandan K; Coombes RC; Medema RH; Hartman J; Lykkesfeldt AE; Lam EW
    Oncogene; 2010 May; 29(20):2983-95. PubMed ID: 20208560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer.
    Zheng ZZ; Xia L; Hu GS; Liu JY; Hu YH; Chen YJ; Peng JY; Zhang WJ; Liu W
    Nucleic Acids Res; 2022 Oct; 50(18):10230-10248. PubMed ID: 36124682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A bi-stable feedback loop between GDNF, EGR1, and ERα contribute to endocrine resistant breast cancer.
    Horibata S; Rice EJ; Zheng H; Mukai C; Chu T; Marks BA; Coonrod SA; Danko CG
    PLoS One; 2018; 13(4):e0194522. PubMed ID: 29614078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.
    Yu-Rice Y; Jin Y; Han B; Qu Y; Johnson J; Watanabe T; Cheng L; Deng N; Tanaka H; Gao B; Liu Z; Sun Z; Bose S; Giuliano AE; Cui X
    Oncogene; 2016 Oct; 35(41):5400-5411. PubMed ID: 27041579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells.
    Nacht AS; Ferrari R; Zaurin R; Scabia V; Carbonell-Caballero J; Le Dily F; Quilez J; Leopoldi A; Brisken C; Beato M; Vicent GP
    EMBO J; 2019 Sep; 38(18):e101426. PubMed ID: 31373033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid Receptor:MegaTrans Switching Mediates the Repression of an ERα-Regulated Transcriptional Program.
    Yang F; Ma Q; Liu Z; Li W; Tan Y; Jin C; Ma W; Hu Y; Shen J; Ohgi KA; Telese F; Liu W; Rosenfeld MG
    Mol Cell; 2017 May; 66(3):321-331.e6. PubMed ID: 28475868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.